REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Osmax Nbt, Inc. (South Korea)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Osmax Nbt, Inc. Profile Updated: July 05, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

The Company is a company mainly engaged in the manufacturing and sale of health functional foods. The Company is engaged in the research and development of functional raw materials and ingredients, the production and sale of health functional foods and health oriented foods.The Company was established on January 2, 2002. The Company share was listed on the Korea Securities Dealers Automated Quotation System ( KOSDAQ ) on December 16,2015.

Headquarters
3F 10 Nonhyeon-Ro 71-Gil, Gangnam-Gu
Seoul; Seoul; Postal Code: 06248

Contact Details: Purchase the Osmax Nbt, Inc. report to view the information.

Basic Information
Total Employees:
Purchase the Osmax Nbt, Inc. report to view the information.
Outstanding Shares:
Purchase the Osmax Nbt, Inc. report to view the information.
Registered Capital:
Purchase the Osmax Nbt, Inc. report to view the information.
Financial Auditors:
Purchase the Osmax Nbt, Inc. report to view the information.
Incorporation Date:
January 02, 2002
Key Executives
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Vice President
Purchase this report to view the information.
Vice President
Purchase this report to view the information.
Managing Director
Purchase this report to view the information.
Managing Director
Ownership Details
Purchase this report to view the information.
38.2%
Purchase this report to view the information.
0.3%
Purchase this report to view the information.
0.2%
Purchase this report to view the information.
Subsidiaries
코스맥스(주)
코스맥스비티아이(주)
코스맥스엔비티(주)
Company Performance
Financial values in the chart are available after Osmax Nbt, Inc. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
-6.52%▼
Total operating revenue
-6.47%▼
Operating profit (EBIT)
-18.17%▼
EBITDA
-9.26%▼
Net Profit (Loss) for the Period
-62.44%▼
Total assets
-6.67%▼
Total equity
-12.3%▼
Operating Profit Margin (ROS)
-0.37%▼
Net Profit Margin
-1.94%▼
Return on Equity (ROE)
-8.21%▼
Debt to Equity Ratio
1.49%▲
Quick Ratio
0.01%▲
Cash Ratio
-0.07%▼

Similar companies

Cj Cheiljedang Corporation
 
SK Discovery Co.,Ltd.
Kt&G Corporation
 
Amore Pacific Group
Samsung Biologics Co., Ltd.
 
Green Cross Holdings Corporation
Glaxo Smithkline Korea Co.,Ltd.
 
St Pharm Co., Ltd.
Samjin Pharmaceutical Co.,Ltd.
 
Pharma Research Products Co.,Ltd.
Korea United Pharm Inc.
 

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo